US pharmaceutical bosses charged with fuelling opioid crisis

US pharmaceutical bosses charged with fuelling opioid crisis

Tuesday, April 23, 2019

Print this page Email A Friend!

NEW YORK, United States (AFP) — Two former executives of a major US pharmaceutical company were charged Tuesday with fulfilling orders they knew to be fraudulent during the opioid epidemic that has claimed tens of thousands of lives.

It was the first time that senior or former executives have faced criminal charges in connection with distributing powerful prescription painkillers like oxycodone and fentanyl that carry a high risk of addiction and overdose.

The company where the executives worked, Rochester Drug Cooperative (RDC), is one of the country's largest distributors of prescription opioids.

It has entered into a non-prosecution agreement with the US Attorney's office in New York and agreed to pay a US$20 million fine.

As result, the company will not be prosecuted and will be allowed to retain its license to distribute drugs, while promising to reform its practices.

In a statement, RDC admitted that between 2012 and 2017 it had failed to report shipments of drugs it recognised as suspicious, as required by law.

"This prosecution is the first of its kind," said US Attorney Geoffrey Berman in a statement.

"Executives of a pharmaceutical distributor and the distributor itself have been charged with drug trafficking, trafficking the same drugs that are fuelling the opioid epidemic that is ravaging this country."

RDC distributes to some 1,300 pharmacies and with an annual turnover of more than US$1 billion, according to documents released by prosecutors.

Investigators found that it had failed to report at least 2,000 suspicious orders of drugs whose distribution is overseen by Drug Enforcement Administration (DEA).

The defendants were named as former CEO Laurence Doud, 75, and William Pietruszewski, 53, who had served as chief compliance officer.

"RDC's employees, including in conversations with Doud and Pietruszewski, described some of the company's customers as 'very suspicious,' and even characteriSed particular pharmacies as a 'DEA investigation in the making' or 'like a stick of dynamite waiting for [the] DEA to light the fuse,'" the New York prosecutors said.

"Nonetheless, throughout the period in question, RDC, at the direction of Doud, increased its sales of oxycodone and fentanyl exponentially," the statement added.

Doud and Pietruszewski were charged with conspiracy to distribute controlled substances, which carries a maximum sentence of life in prison and a minimum of 10 years.

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at




1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed:

6. If readers wish to report offensive comments, suggest a correction or share a story then please email:

7. Lastly, read our Terms and Conditions and Privacy Policy

comments powered by Disqus



Today's Cartoon

Click image to view full size editorial cartoon